Standard Adjuvant Endocrine Therapy is named as a drug or biological intervention in 2 clinical trials in our Ireland, UK, USA, India and China trial registers, none of which are currently recruiting. Lead sponsors include Alliance Foundation Trials, LLC. (1) and Eli Lilly and Company (1). Registered phase: Phase 3. Conditions studied include Breast Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT02513394 | PALbociclib CoLlaborative Adjuvant Study (ClinicalTrials.gov ↗) Breast Cancer |
Phase 3 | Active, closed |
| NCT03155997 | Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (ClinicalTrials.gov ↗) Breast Cancer |
Phase 3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Breast Cancer | 2 |
| Lead sponsor | Trials |
|---|---|
| Alliance Foundation Trials, LLC. | 1 |
| Eli Lilly and Company | 1 |
| Register | Standard Adjuvant Endocrine Therapy trials |
|---|---|
| Clinical trials in Ireland | 1 |
| Clinical trials in UK | 1 |
| Clinical trials in USA | 1 |
| Clinical trials in India | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Standard Adjuvant Endocrine Therapy works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Standard Adjuvant Endocrine Therapy (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.